Clinical trial
Development of a Decision Aid to Facilitate Ovarian Cancer Patient's Choices Regarding Biomarker CA125
NCT03004391 is registered in ClinicalTrials.gov with Vejle Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Development of a Decision Aid to Facilitate Ovarian Cancer Patient's Choices Regarding Biomarker CA125
- Lead sponsor
- Vejle Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 1, 2017
- Completion date
- December 31, 2022
- Enrollment
- 25 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ovarian cancer